Eliquis, Jardiance, and Stelara are among the first of 10 different drugs that are now subject to Medicare price negotiations following the passing of the Inflation Reduction Act.
The list includes Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and Fiasp. Shares of the drugmakers were little changed in the premarket session Tuesday. Bristol Myers was up 0.5%, Eli Lilly gained 0.2%, Johnson & Johnson declined 0.2%, Merck was flat, American depositary receipts of AstraZeneca dropped 0.5%, American depositary receipts of Novartis were down 0.1%, Amgen slipped 0.1%, AbbVie declined 0.5% and American depositary receipts of Novo Nordisk were flat.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação: